Srinivas Akkaraju

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Palo Alto, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sanam Pangali, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Srinivas Akkaraju

Form 4 holding Director

ALUMIS INC.

Security class
Common Stock
Shares / value
4,491,731
Estimated value
$98,952,833
Report date
30 Jun 2026
Price
$22.03
Ownership
By Samsara BioCapital, L.P.
Form 4 holding Director

ALUMIS INC.

Security class
Common Stock
Shares / value
1,853,488
Estimated value
$40,832,340
Report date
30 Jun 2026
Price
$22.03
Ownership
By Samsara Opportunity Fund, L.P.
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
1,548,101
Estimated value
$23,221,515
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara BioCapital, L.P.
Underlying class
Class A Common Stock
Underlying amount
1,548,101
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Warrant (Right to Buy)
Shares / value
983,214
Estimated value
$14,748,210
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara Opportunity Fund, L.P.
Underlying class
Class A Common Stock
Underlying amount
983,214
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
877,214
Estimated value
$13,158,210
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara Opportunity Fund, L.P.
Underlying class
Class A Common Stock
Underlying amount
877,214
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
1,548,101
Estimated value
$10,532,420
Report date
03 Sep 2025
Price
$11.80
Ownership
Samsara BioCapital, L.P.
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Warrant (Right to Buy)
Shares / value
655,523
Estimated value
$9,832,845
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara BioCapital, L.P
Underlying class
Class A Common Stock
Underlying amount
655,523
Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
2,667
Estimated value
$4,470
Report date
16 Sep 2024
Price
$1.68
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Jiya Acquisition Corp.

Security class
Class B Common Stock
Shares / value
2,437,114
Estimated value
Report date
23 Sep 2022
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Warrant to Purchase Class A Common Stock (Right to Buy)
Shares / value
655,523
Estimated value
Report date
03 Sep 2025
Price
Ownership
By Samsara BioCapital, L.P.
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

ALUMIS INC.

Security class
Stock Option (Right to Buy)
Shares / value
15,528
Estimated value
Report date
30 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
6,000
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CHINOOK THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$39.03
Ownership
By Samsara BioCapital, L.P.
Form 4 holding Director

CHINOOK THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$26.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INTERCEPT PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
08 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Scholar Rock Holding Corp

Security class
Warrants to Purchase Common Stock
Shares / value
0
Estimated value
Report date
12 Dec 2025
Price
Ownership
By Samsara BioCapital LP
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Srinivas Akkaraju

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .